Physician profile
William Aaron Ross
NPI 1346365418
$3,526.08
in general payments reported to CMS, 2019-2025
8 companies · $86.32 in 2025
The $86.32 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,863 · 2020: $240 · 2021: $120 · 2023: $92.84 · 2024: $125 · 2025: $86.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $303.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $3,052.69 | 2019-2021 | |
| Integra Lifesciences Corporation | $169.43 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $124.80 | 2024 | Eylea Hd |
| Mentor Worldwide LLC | $71.94 | 2025 | Mentor Memorygel Resterilizable Gel Sizer, Prolene |
| Merz North America, INC. | $37.60 | 2023 | Xeomin |
| Abbvie INC. | $32.24 | 2023 | |
| Galderma Laboratories, L.P. | $23.00 | 2023 | Dysport |
| Vertex Pharmaceuticals Incorporated | $14.38 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.